{"extraction_ratio": 0.96, "to_compare": [{"generated": ["progressive mobilization", "complete normalization of the laboratory findings"], "gold": []}, {"generated": ["rhabdomyolysis", "alternative herbal medicine", "heavy toxicity", "trabectedin"], "gold": []}, {"generated": ["complete margin negative (R0) resection", "abdominal mass"], "gold": []}, {"generated": ["location", "lesion size"], "gold": []}, {"generated": ["other drugs", "co-morbidity"], "gold": []}, {"generated": ["ancillary medications", "combinations in oncology practice", "narrow therapeutic index", "prolonged life expectancy", "chemotherapeutic drugs"], "gold": []}, {"generated": ["transport mechanisms", "death receptor", "unknown mechanisms"], "gold": []}, {"generated": ["health risks", "medicinal cannabis"], "gold": []}, {"generated": ["HTR2A", "COMT"], "gold": []}, {"generated": ["dopamine concentrations"], "gold": []}, {"generated": ["pharmacogenomic data", "pharmacokinetic", "pharmacodynamic"], "gold": []}, {"generated": ["frequent falls", "chronic neck pain", "chronic back pain", "spinal stenosis", "alcohol dependence", "chronic shoulder pain", "mild kidney disease", "nicotine dependence", "vitamin D deficiency"], "gold": []}, {"generated": ["tremors"], "gold": []}, {"generated": ["additional medication for pain control"], "gold": []}, {"generated": ["pain models", "routes of administration", "healthy subjects vs. patients", "sources of the product"], "gold": []}, {"generated": ["inhibitory neurotransmitter levels", "dopamine levels"], "gold": ["dopamine levels"]}, {"generated": ["COMT Met/Met"], "gold": []}, {"generated": ["hallucinations"], "gold": []}, {"generated": ["morphine"], "gold": []}, {"generated": ["Katie Meyer"], "gold": []}, {"generated": ["conventional medicines", "CAM"], "gold": []}, {"generated": ["CAM"], "gold": []}, {"generated": ["range"], "gold": []}, {"generated": ["therapeutic indices"], "gold": []}, {"generated": ["HDIs"], "gold": []}, {"generated": ["clinic study", "pharmacogenomics studies", "important herb products", "HDIs"], "gold": []}, {"generated": ["TPMT gene", "hypoglycemic effect"], "gold": ["The rs1142345 (A>G) SNP in the thiopurine S-methyltransferase (TPMT) gene"]}, {"generated": ["clinical effect of traditional hypoglycemic herbs"], "gold": ["rs1142345"]}, {"generated": ["PM", "AUC: concentration-time curve", "EMs"], "gold": ["AUC: concentration-time curve"]}, {"generated": ["herbal remedies", "conventional therapeutic drugs"], "gold": []}, {"generated": ["Faangum", "Lifui", "Sasanemasa/Sesemasa", "Akoko"], "gold": []}, {"generated": ["cytochrome P450"], "gold": []}, {"generated": ["CYP2C9", "CYP2C19", "CYP1A2"], "gold": []}, {"generated": ["K A", "metabolites"], "gold": []}, {"generated": ["% yield", "bioavailable concentration"], "gold": ["bioavailability", "bioavailable concentration"]}, {"generated": ["HDI", "DDI studies"], "gold": []}, {"generated": ["TDI effects", "intermediary metabolites"], "gold": []}, {"generated": ["water"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Micromass Xevo tandem quadrupole mass spectrometric detector", "UPLC system", "binary pump", "NADP Phytofingerprinting", "Acquity BEH C18 column", "autosampler", "regeneration system", "ESI probe", "serial dilutions", "vacuum degasser", "column oven"], "gold": []}, {"generated": ["HDI", "DDI models", "IVIVE"], "gold": []}, {"generated": ["OATs", "SLC22 family members"], "gold": ["SLC22", "OATs"]}, {"generated": ["unique substrates"], "gold": ["Oat1", "Oat3"]}, {"generated": ["clinical pharmacokinetic profile", "Danshen components"], "gold": ["transporter families", "the OATs"]}, {"generated": ["CYP2C9", "gliclazide", "St John's wort", "pharmacodynamics", "genotype", "pharmacokinetics"], "gold": []}, {"generated": ["alternative medicines"], "gold": []}, {"generated": ["6\u03b1", "7\u03b1", "6\u03b2", "7\u03b2"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["CYP2C9*3", "CYP2C9*2"], "gold": []}, {"generated": ["human genomic DNA", "PCR"], "gold": []}, {"generated": ["grapefruit", "caffeine-containing beverages"], "gold": []}, {"generated": ["(2003)"], "gold": []}, {"generated": ["CL/Fs", "CYP2C9*3 allele", "tolbutamide", "glipizide"], "gold": ["CL/Fs"]}, {"generated": [], "gold": []}, {"generated": ["serological titers for Epstein Barr virus", "serological titers for acute CMV"], "gold": []}, {"generated": ["smooth muscle antibody", "Antinuclear antibody (ANA)"], "gold": ["Antinuclear antibody (ANA", "smooth muscle antibody"]}, {"generated": ["plasma cell rich interface hepatitis", "chronic hepatitis", "cholangiolar proliferation", "portal tracts", "periportal hepatocyte apoptosis"], "gold": ["periportal hepatocyte"]}, {"generated": ["clinicopathological features"], "gold": []}, {"generated": ["right upper quadrant abdominal pain", "fatigue", "lower extremity edema"], "gold": []}, {"generated": ["vasomotor symptoms of menopause"], "gold": []}, {"generated": ["liver failure"], "gold": []}, {"generated": ["immunogen", "hapten", "autoimmune response"], "gold": []}, {"generated": ["Naranjo Causality Scale"], "gold": []}, {"generated": ["black cohosh hepatotoxicity"], "gold": []}, {"generated": ["third-generation fluoroquinolone antibiotic family"], "gold": []}, {"generated": ["Relinqing\u00ae granule", "LVFX", "Polygonum capitatum"], "gold": []}, {"generated": ["pharmacokinetic features"], "gold": []}, {"generated": ["rat tissue homogenate", "puerarin"], "gold": []}, {"generated": ["42 mg\u00b7kg"], "gold": []}, {"generated": ["LVFX", "complex matrices"], "gold": []}, {"generated": ["integrities"], "gold": []}, {"generated": ["LVFX", "distribution rate"], "gold": []}, {"generated": ["pharmacokinetic level"], "gold": []}, {"generated": ["pharmacodynamic interactions", "pharmacokinetic interactions"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["efficacy"], "gold": []}, {"generated": ["anti-inflammatory", "anticancer", "anti-osteoporosis", "antioxidant"], "gold": []}, {"generated": ["Trypsin EDTA", "Hanks balanced salt solution (HBSS)", "Dulbecco\u2019s Modified Eagle Medium (DMEM)", "Sodium Pyruvate", "Minimal Essential Medium (MEM)", "Penicillin-streptomycin", "HEPES"], "gold": []}, {"generated": ["DMEM", "FBS", "reversible inhibition", "non-essential amino acids", "MDCK-II cells"], "gold": []}, {"generated": ["alkyl phenols", "triterpene glycosides"], "gold": []}, {"generated": ["P-gp"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["CYP2C9", "CYP2C8", "Cytochrome P450 enzymes", "CYP3A4"], "gold": []}, {"generated": ["anti-obesity", "anti-diabetic", "cardio-protective effects"], "gold": []}, {"generated": ["CYP2C9", "CYP2C8", "CYP3A4"], "gold": []}, {"generated": ["CYP2C9", "CYP2C8", "CYP3A4"], "gold": []}, {"generated": ["DMSO", "acetonitrile", "methanol"], "gold": []}, {"generated": ["CYP2C9", "CYP2C8", "CYP3A4"], "gold": []}, {"generated": ["FRE", "CYP2C9", "CYP3A4 activity"], "gold": []}, {"generated": ["Stock solutions", "10 mg/mL"], "gold": []}, {"generated": ["sulfaphenazole", "quercetin", "ketoconazole"], "gold": []}, {"generated": ["safety", "pharmacodynamics"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Echinacea", "participants"], "gold": []}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": ["statistically significant"], "gold": []}, {"generated": ["pharmacokinetics of docetaxel"], "gold": []}, {"generated": ["caffeic acid derivatives", "alkylamides"], "gold": []}, {"generated": ["docetaxel", "grade 3 and 4 toxicities", "NCI CTCAE, version 3.0"], "gold": []}, {"generated": ["plasma"], "gold": []}, {"generated": ["elimination half-life (t1/2)", "maximum plasma concentration (Cmax)", "AUC0\u2013\u221e"], "gold": ["area under the plasma concentration\u2013time curve from time zero to infinity (AUC0\u2013\u221e)", "elimination half-life (t1/2)", "maximum plasma concentration (Cmax)"]}, {"generated": ["t1/2", "AUC0\u2013\u221e", "Cmax"], "gold": ["AUC0\u2013\u221e", "t1/2", "Cmax"]}, {"generated": ["docetaxel AUC0\u2013\u221e"], "gold": ["AUC0\u2013\u221e"]}, {"generated": ["midazolam", "dosing regimen", "dose", "CYP3A4 induction"], "gold": []}, {"generated": ["total amount of extract"], "gold": []}, {"generated": ["DTAI", "alkylamides"], "gold": []}, {"generated": ["DTAI", "alkylamide content"], "gold": []}, {"generated": ["CYP3A4 induction"], "gold": []}, {"generated": ["docetaxel pretreatment", "dexamethasone"], "gold": []}, {"generated": ["plasma levels of docetaxel"], "gold": []}, {"generated": ["tumour progression"], "gold": []}, {"generated": ["CYP3A4-mediated interactions"], "gold": []}, {"generated": ["p-glycoprotein (p-gp)"], "gold": []}, {"generated": ["plasma", "ethyl gallate", "ethyl acetate", "ascorbic acid-EDTA solution"], "gold": []}, {"generated": ["M/Z values"], "gold": []}, {"generated": ["calibration curve range", "EGC", "ECG", "EGCG", "EC"], "gold": []}, {"generated": ["DNA"], "gold": []}, {"generated": ["rs1045642", "G2677T", "G2677A", "C3435T", "rs2032582", "ABCB1", "rs1128503", "C1236T"], "gold": []}, {"generated": ["adverse events"], "gold": []}, {"generated": ["adverse events"], "gold": []}, {"generated": ["AUC", "EGC", "ECG", "concentration\u2013time profiles", "EGCG", "EC", "pharmacokinetics parameters"], "gold": ["AUC"]}, {"generated": ["AUC"], "gold": ["AUC"]}, {"generated": ["systemic exposure"], "gold": []}, {"generated": ["AUC", "Subject baseline characteristics"], "gold": ["AUC", "AUC"]}, {"generated": ["biliary excretion"], "gold": ["Biliary excretion", "urinary excretion"]}, {"generated": ["plasma concentrations of ginsenosides"], "gold": []}, {"generated": ["biliary excretion", "Mrp2 substrate drug"], "gold": []}, {"generated": ["Rg3", "Re", "Rh1"], "gold": []}, {"generated": ["bile acid receptor", "P-gp"], "gold": []}, {"generated": ["rheumatoid arthritis symptoms"], "gold": []}, {"generated": ["red ginseng", "MTX"], "gold": []}, {"generated": ["Mrp2 regulation changes"], "gold": []}, {"generated": ["total RNA"], "gold": []}, {"generated": ["total protein"], "gold": []}, {"generated": ["pharmacokinetic studies"], "gold": []}, {"generated": ["red ginseng extract"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["ginsenosides"], "gold": []}, {"generated": ["Bautista et al."], "gold": []}, {"generated": ["Dybro et al."], "gold": []}, {"generated": ["AC", "DST"], "gold": []}, {"generated": ["3.5 \u03bcm"], "gold": []}, {"generated": ["supernatant"], "gold": []}, {"generated": ["metabolic rate", "maximum plasma concentration", "liver microsomes"], "gold": []}, {"generated": ["half-life"], "gold": []}, {"generated": ["acetonitrile"], "gold": []}, {"generated": ["selectivity", "plasma samples"], "gold": []}, {"generated": ["concentration range"], "gold": []}, {"generated": ["accuracy", "precision"], "gold": []}, {"generated": ["effective plasma drug concentration"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Western drugs"], "gold": []}, {"generated": ["digoxin plasma concentration"], "gold": []}, {"generated": ["digoxin"], "gold": []}, {"generated": ["Chuanxiong", "P-gP", "Ginkgo biloba L.", "Tapinanthus sessilifolius", "Biantaobanjiuju", "Carica papaya"], "gold": []}, {"generated": ["AUC"], "gold": ["AUC"]}, {"generated": ["Li Xin"], "gold": []}, {"generated": ["ventricular tachycardia", "digoxin-induced arrhythmias", "ventricular fibrillation", "QRS interval prolongation", "ventricular precontraction", "flavane polymers", "vascular dilation", "blood pressure", "cardiovascular system", "flavonoid glycoside", "heart rhythm"], "gold": ["blood pressure", "heart rhythm"]}, {"generated": ["yang", "blood", "yin", "qi"], "gold": []}, {"generated": ["TCM formulations"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["TCM formulations", "digoxin"], "gold": []}, {"generated": ["herb-drug interactions"], "gold": []}, {"generated": ["cytochrome P450"], "gold": ["cytochrome P450 (P450)", "monooxygenase forms"]}, {"generated": ["systemic levels of the victim drug"], "gold": []}, {"generated": ["drug-metabolizing enzymes", "type of extract (CAW)"], "gold": []}, {"generated": ["drug disposition", "nuclear receptor agonists", "transporter function"], "gold": ["nuclear receptor"]}, {"generated": ["Plant Material", "C. asiatica", "CAW-R61J"], "gold": []}, {"generated": ["dried CA", "CAW-R61F", "CAW-R61H"], "gold": []}, {"generated": ["DMSO"], "gold": ["DMSO", "DMSO"]}, {"generated": ["ambient temperature"], "gold": []}, {"generated": ["NADPH", "P450 enzyme activity", "IC50 values"], "gold": ["Potential TDI of P450 enzyme activity", "IC50", "NADPH"]}, {"generated": [], "gold": []}, {"generated": ["concentration-response", "percentage control value", "IC50 values", "four-parameter sigmoid (Hill) model"], "gold": ["the IC50 values", "the concentration-response (percentage control value)"]}, {"generated": ["logEC50"], "gold": ["logEC50", "logIC50"]}, {"generated": ["curve fitting"], "gold": []}, {"generated": ["dmd.120.090860f1"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["CYP2C9", "CYP2B6", "CYP1A2"], "gold": ["IC50", "IC50"]}, {"generated": [""], "gold": []}, {"generated": ["dmd.120.090860f3"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["triplicate determinations"], "gold": []}, {"generated": ["human P450 forms", "CYP2C9", "CYP2D6", "CYP2C19", "human liver microsomes", "CYP3A4", "centelloids"], "gold": ["P450", "CYP2C19, CYP3A4, CYP2D6, and CYP2C9"]}, {"generated": ["plasma concentrations"], "gold": ["plasma concentrations for these compounds"]}, {"generated": ["CAW-R61J compounds", "IC50 values"], "gold": ["IC50", "in vivo concentration"]}, {"generated": ["phase II drug-metabolizing enzymes"], "gold": ["phase II drug-metabolizing enzymes"]}, {"generated": ["safety", "tolerability", "DDI potential"], "gold": []}, {"generated": ["chronic kidney disease", "hypertension"], "gold": []}, {"generated": ["fimasartan-amide", "amlodipine", "fimasartan", "hydrochlorothiazide"], "gold": []}, {"generated": ["standard calibration curves", "concentrations"], "gold": []}, {"generated": ["berberine (IS)", "1 ng/mL"], "gold": []}, {"generated": ["QC samples", "post-preparative stability", "6 \u00b0C", "autosampler"], "gold": []}, {"generated": ["hydrochlorothiazide", "amlodipine", "fimasartan"], "gold": []}, {"generated": ["jejunal segments", "pre-warmed saline"], "gold": []}, {"generated": ["berberine", "amlodipine", "acetonitrile"], "gold": []}, {"generated": ["ionization mode", "mass transition from Q1 to Q3"], "gold": []}, {"generated": ["hydrochlorothiazide", "amlodipine", "fimasartan", "chromatograms"], "gold": []}, {"generated": ["inter-day accuracy", "Guideline of Bioanalytical method validation", "intra-day accuracy", "standard curve sample", "QC sample"], "gold": []}, {"generated": ["hypertension", "fimasartan combination therapy", "fimasartan monotherapy"], "gold": []}, {"generated": ["mass fragmentation patterns"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["CV", "mean"], "gold": []}, {"generated": ["HAART administration"], "gold": []}, {"generated": ["quality of life"], "gold": []}, {"generated": ["nausea", "diarrhoea", "dyslipidemia", "fever", "headache", "vomiting", "liver damage"], "gold": []}, {"generated": ["medicinal plants"], "gold": []}, {"generated": ["mechanisms of action"], "gold": []}, {"generated": ["CYP2B6"], "gold": []}, {"generated": ["GI tract", "soluble extract", "bioavailable concentration"], "gold": ["bioavailability", "bioavailable concentration"]}, {"generated": ["Caffeic acid", "Chlorogenic acid", "p-Coumaric acid", "Epicatechin", "Catechin"], "gold": []}, {"generated": ["mechanistic studies", "phytochemical profiling", "drug interacting constituents"], "gold": []}, {"generated": ["CYP2B6"], "gold": []}, {"generated": ["Ethical approval", "University of Cape Town Human Research Ethics committee", "HREC REF: 826/2014"], "gold": []}, {"generated": ["solid residue", "supernatant", "purified water"], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["drug interactions"], "gold": []}, {"generated": ["7 \u00b1 1-day washout period"], "gold": []}, {"generated": ["GGT"], "gold": []}, {"generated": ["1000 mg", "AAP dose", "maximum dose", "8 tablets"], "gold": []}, {"generated": ["GGT 7680 mg once daily", "AAP 1000 mg once daily", "AAP 1000 mg \u00d7 4 times daily"], "gold": []}, {"generated": ["GGT", "AAP dosage"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pharmacokinetic (PK) parameters"], "gold": []}, {"generated": ["CYP2D6", "CYP2E1", "CYP3A4", "CYP1A2"], "gold": []}, {"generated": ["individuals greater than 65 years of age", "herbal supplement usage", "patients taking prescription medications"], "gold": []}, {"generated": ["CYP enzymes", "CYP substrates", "pharmacokinetics"], "gold": []}, {"generated": ["probe drug administration"], "gold": []}, {"generated": ["ultraviolet absorption spectra", "retention times"], "gold": []}, {"generated": ["serious adverse events"], "gold": []}, {"generated": ["Phenotypic Ratio (CYP)"], "gold": []}, {"generated": ["phenotypic ratio", "midazolam clearance"], "gold": ["area-under-the-curve", "clearance"]}, {"generated": [""], "gold": []}, {"generated": ["St. John\u2019s wort"], "gold": []}, {"generated": ["CYP2E1 responsivity", "allyl sulfide content"], "gold": []}, {"generated": ["anticoagulant therapy"], "gold": []}, {"generated": ["platelet activating factor"], "gold": []}, {"generated": ["G. biloba", "CYP isoforms", "herb-drug interactions"], "gold": []}, {"generated": ["Panax ginseng", "CYP isoforms"], "gold": []}, {"generated": ["ginseng-mediated induction", "CYP2C9"], "gold": []}, {"generated": ["herb-drug interactions"], "gold": []}, {"generated": ["3-hydroxyquinine", "plasma quinine"], "gold": []}, {"generated": ["metallic ions", "calcium", "biflavonoid complex", "copper", "xanthones", "aluminum", "alkaloids", "kolaviron", "magnesium", "tannins", "phenols", "benxophenones", "saponins"], "gold": []}, {"generated": ["breastfeeding", "histories of hypersensitivity to quinine or similar agents", "adverse side effects from taking G. kola seeds", "pregnancy"], "gold": []}, {"generated": ["certified healthy", "written informed consent"], "gold": []}, {"generated": ["600 mg", "quinine sulphate tablets"], "gold": []}, {"generated": ["quinine alone", "1, 2, 3,4, 6, 8, 12, 24, 36 and 48 h", "time zero", "quinine sulphate tablets", "concurrently with the scheduled dose of G. kola"], "gold": []}, {"generated": ["3-hydroxyquinine", "quinine"], "gold": []}, {"generated": ["AUC0\u2013\u221e"], "gold": ["AUC0\u2013\u221e"]}, {"generated": ["dizziness"], "gold": []}, {"generated": ["flavonoids", "quinine", "trace metals"], "gold": ["Cmax", "tmax"]}, {"generated": ["T1/2", "CL/F"], "gold": ["T1/2", "CL/F"]}, {"generated": [""], "gold": []}, {"generated": ["77 additional participants"], "gold": []}, {"generated": ["TCAM"], "gold": []}, {"generated": ["failure differences"], "gold": []}, {"generated": ["QRS duration", "PR interval", "corrected QT interval (QTc)"], "gold": ["the PR interval", "QRS duration", "corrected QT interval (QTc)"]}, {"generated": ["P-value for interaction effect of groups over time", "LDL", "HDL"], "gold": ["HDL (high density lipoprotein)", "LDL (low density lipoprotein)"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["prevalence"], "gold": []}, {"generated": ["Chronic kidney disease (CKD)"], "gold": []}, {"generated": ["drug interactions"], "gold": []}, {"generated": ["occupational status", "marital status", "age", "educational status", "sex"], "gold": []}, {"generated": ["age group", "male/female ratio"], "gold": []}, {"generated": ["acute kidney injury", "polycystic kidney disease", "congenital kidney disease", "drug-induced renal failure"], "gold": []}, {"generated": ["herbal usage prevalence", "age range of 50\u201370 years"], "gold": []}, {"generated": ["age groups"], "gold": []}, {"generated": ["respiratory problems", "common cold"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["TEM", "Karnofsky performance status scale"], "gold": []}, {"generated": ["residual tumor", "positron emission tomography"], "gold": []}, {"generated": ["education about the risk of interactions with herbal formulas"], "gold": []}, {"generated": ["whole blood", "normal saline", "incubation"], "gold": []}, {"generated": ["International normalized ratio"], "gold": ["International normalized ratio", "International normalized ratio"]}, {"generated": ["factor activity", "clotting time"], "gold": ["clotting time"]}, {"generated": ["apparent volume of distribution (V/F)", "half-life", "apparent clearance (CL/F)"], "gold": ["half-life", "CL/F", "AUC0\u2212\u221e", "CL/kel"]}, {"generated": ["INR data", "prothrombin complex activity", "S-warfarin concentration"], "gold": ["prothrombin complex activity (PCA", "INR"]}, {"generated": [], "gold": []}, {"generated": ["CL/Fs", "AUC", "fu", "CL/F"], "gold": ["tmax", "Cmax", "AUC", "CL/F", "tmax", "Cmax", "t1/2", "AUC", "CL/F", "AUC, area under the plasma concentration\u2013time curve", "CL, clearance", "CL/F, apparent clearance", "Cmax, maximum concentration", "F, bioavailability", "tmax, time to Cmax"]}, {"generated": ["population PKPD parameter estimates"], "gold": []}, {"generated": ["AUC of S-warfarin"], "gold": ["AUC"]}, {"generated": ["atrial fibrillation"], "gold": []}, {"generated": ["warfarin", "cranberry juice", "pharmacodynamic interactions"], "gold": []}, {"generated": ["complementary medicines", "herb\u2013drug interaction"], "gold": []}, {"generated": ["anticancer drugs"], "gold": []}, {"generated": ["CYP 3A4"], "gold": []}, {"generated": ["the elderly"], "gold": []}, {"generated": ["tablets", "daily doses", "capsules", "valerian root extracts"], "gold": []}, {"generated": ["valerian", "valeriana"], "gold": []}, {"generated": ["potential bias in the presentation of results and conclusions", "clinical relevance of the results", "completeness and validity of data"], "gold": []}, {"generated": ["clinical relevance"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["500\u2009mg valerian extract"], "gold": []}, {"generated": ["CYP 3A4/5", "CYP 1A2", "CYP 2D6", "CYP 2E1"], "gold": []}, {"generated": ["12 weeks", "15 days", "Haloperidol"], "gold": []}, {"generated": ["two drugs"], "gold": []}, {"generated": ["pharmacodynamic interaction"], "gold": []}, {"generated": ["MAO-inhibitory properties", "opioids", "delirium"], "gold": []}, {"generated": ["drug-drug interactions"], "gold": []}, {"generated": ["in vivo bioavailability", "metabolism of extract components"], "gold": ["bioavailability"]}, {"generated": ["pharmacodynamic interactions"], "gold": []}, {"generated": ["interactions", "therapeutic safety"], "gold": []}, {"generated": ["CYP-isoenzymes", "UGT", "P-gp"], "gold": []}, {"generated": ["warnings regarding a specific risk of interactions"], "gold": []}, {"generated": ["conflict of interests"], "gold": []}, {"generated": ["CYP3A induction", "CYP3A inhibition"], "gold": []}, {"generated": ["serotonin-norepinephrine reuptake inhibitor"], "gold": []}, {"generated": ["radiological abnormalities", "LVEF"], "gold": ["LVEF"]}, {"generated": ["drug-induced cardiopulmonary toxicity"], "gold": []}, {"generated": ["DIP", "reversibility"], "gold": []}, {"generated": ["cardiopulmonary toxicity"], "gold": []}, {"generated": ["detection of autoimmune diseases", "studies of imaging", "LBA", "myocardial biopsy", "cardiac catheterization"], "gold": []}, {"generated": ["inhibidores da isoenzima CYP2D6", "fen\u00f3tipo de metaboliza\u00e7\u00e3o lenta de CYP2D6"], "gold": []}, {"generated": ["prote\u00ednas do complemento", "sedimento urin\u00e1rio", "hep\u00e1ticos", "renais"], "gold": []}, {"generated": ["medicamentos card\u00edacos"], "gold": []}, {"generated": ["paciente", "h\u00edgida", "35 anos de idade"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["safety", "red ginseng", "herb extract complex (RHC)", "menopausal symptoms"], "gold": []}, {"generated": ["mammographies", "aspartate aminotransferase (AST)", "creatinine levels", "Pap smears", "alanine aminotransferase (ALT)"], "gold": ["fasting blood sugar", "triglyceride", "cholesterol", "alanine aminotransferase (ALT)", "aspartate aminotransferase (AST)", "creatinine"]}, {"generated": ["treatment of adverse reactions", "name of the drug other than the test substance", "date of disappearance", "causal relationship with the test substance", "date of onset", "degree and result of the adverse reaction"], "gold": []}, {"generated": ["characteristics", "demographic information"], "gold": []}, {"generated": ["p-value"], "gold": []}, {"generated": ["headache", "pruritus", "hot flash"], "gold": []}, {"generated": ["severe adverse reactions"], "gold": []}, {"generated": ["safety of RHC intake"], "gold": []}, {"generated": ["UGT1A1-mediated 4-MU glucuronidation", "UGT2B7-catalyzed 4-MU glucuronidation"], "gold": []}, {"generated": ["inhibition of compounds towards UGT isoforms"], "gold": []}, {"generated": ["competitive inhibition"], "gold": []}, {"generated": ["inhibition kinetic parameter (Ki)"], "gold": []}, {"generated": ["serotonin glucuronidation", "UGT1A6 expression"], "gold": []}, {"generated": ["valproic acid", "clofibric acid"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["4-MU glucuronidation", "UGT2B7"], "gold": []}, {"generated": ["anti-inflammatory", "anti-diabetic", "anti-oxidative"], "gold": []}, {"generated": ["CYP2C9", "probe substrates for five cytochrome P450 (CYP) enzymes", "CYP2D6", "CYP2C19", "CYP3A", "CYP1A2"], "gold": []}, {"generated": ["ginsenosides", "Oatp", "RGE", "OATP"], "gold": []}, {"generated": ["herb\u2013drug interactions involving valsartan"], "gold": []}, {"generated": ["plasma concentration", "unbound fraction of tri-glycosylated PPD-type ginsenosides"], "gold": []}, {"generated": ["ginsenosides", "plasma samples", "valsartan"], "gold": []}, {"generated": ["0.67", "8", "0.33", "24", "0.17", "2", "1.5", "48", "4"], "gold": []}, {"generated": ["Rb2", "Rb1", "Rc", "PPT", "Rd", "PPD"], "gold": []}, {"generated": ["AUC", "dose", "pharmacokinetic parameters", "plasma concentration-time curve", "rats", "intravenous injection", "valsartan", "Rc"], "gold": ["AUC: area under the plasma"]}, {"generated": ["safety", "potential for interactions with other drugs", "efficacy"], "gold": ["efficacy and safety"]}, {"generated": ["deviation of \u00b11 day"], "gold": []}, {"generated": ["study participants"], "gold": []}, {"generated": ["CAT", "MDA", "SOD", "GPx"], "gold": ["catalase (CAT)", "glutathione peroxidase (GPx)", "superoxide dismutase (SOD)", "malondialdehyde (MDA)"]}, {"generated": ["antioxidant and polyphenolic properties"], "gold": []}, {"generated": ["blood glucose", "insulin"], "gold": ["insulin", "blood glucose"]}, {"generated": ["polymethoxylated flavonoids (PMF)", "terpenoids (limonene and linalool)", "cytoprotective effects", "hesperidin"], "gold": []}, {"generated": ["CAT", "MDA", "SOD", "antioxidants"], "gold": ["SOD", "CAT", "MDA"]}, {"generated": ["Folin-Ciocalteau reagent", "hydrodistillation", "Na Total flavonoids", "Clevenger type apparatus"], "gold": []}, {"generated": ["standard", "reference value", "calibration curve"], "gold": []}, {"generated": ["standard deviation (SD)", "measures of central tendency", "mean", "percentage", "frequency", "measures of dispersion"], "gold": []}, {"generated": ["CC with herbal mixture", "herbal mixture", "CC"], "gold": []}, {"generated": ["HOMA-IR level", "FBS level", "insulin level"], "gold": ["FBS level", "insulin level", "HOMA-IR level"]}, {"generated": ["antioxidant activity"], "gold": []}, {"generated": ["CAT", "MDA", "SOD", "GPx"], "gold": ["SOD", "CAT", "GPx", "MDA"]}, {"generated": ["FBS level", "pancreatic \u03b2 cells", "insulin", "serotonin receptors"], "gold": ["FBS level"]}, {"generated": ["spearmint", "phenolic phytochemicals"], "gold": []}, {"generated": ["glucose levels", "insulin tolerance"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["sexual hormones", "lipid profile", "proliferative phase", "secretory phase"], "gold": []}, {"generated": ["Polycystic ovary syndrome (PCOS)"], "gold": []}, {"generated": ["volatile compounds"], "gold": []}, {"generated": ["darunavir concentrations"], "gold": []}, {"generated": ["Spain", "V05895B", "Madrid", "Arkopharma"], "gold": []}, {"generated": ["physical examination", "chemistry", "blood counts", "HIV-1 RNA load", "clinical interview", "CD4+ T-cell count"], "gold": ["blood counts", "CD4+ T-cell count"]}, {"generated": ["pharmacokinetic parameters", "confidence intervals", "analysis of variance model", "treatment as a fixed effect", "natural log transformed"], "gold": []}, {"generated": ["CD4+ T-cell count"], "gold": ["CD4+ T-cell count"]}, {"generated": ["HIV-1 RNA load"], "gold": ["HIV-1 RNA load"]}, {"generated": ["Darunavir pharmacokinetics"], "gold": []}, {"generated": ["C\u03c4", "darunavir pharmacokinetic parameters", "AUC\u03c4"], "gold": ["C\u03c4", "AUC\u03c4"]}, {"generated": ["ritonavir concentration-versus-time profile", "pharmacokinetic parameters"], "gold": []}, {"generated": ["clinical pharmacokinetic interactions"], "gold": []}, {"generated": ["darunavir pharmacokinetics", "CYP3A4 inductive/inhibitory potential"], "gold": []}, {"generated": ["E. purpurea"], "gold": []}, {"generated": ["major CYP enzymes", "metabolic drug\u2013drug interactions"], "gold": ["CYP enzymes"]}, {"generated": ["Ginkgo biloba extract"], "gold": []}, {"generated": ["EGb 761\u00ae 120 mg", "EGb 761\u00ae 240 mg"], "gold": []}, {"generated": ["5-OH-OME", "OME", "MID", "DOR", "DEX"], "gold": []}, {"generated": ["phenotyping metrics", "bioequivalence approach", "adjusted margins"], "gold": []}, {"generated": ["EGb 761"], "gold": []}, {"generated": ["EGb 761\u00ae daily dose", "CYPs induction", "steady state", "exposure duration"], "gold": []}, {"generated": ["CYP2C9", "CYP1A2"], "gold": ["CYP1A2", "CYP2C9"]}, {"generated": ["CYP2C19 activity"], "gold": ["CYP2C19 activity"]}, {"generated": ["pharmacodynamic (PD) parameters", "pharmacokinetic (PK) parameters"], "gold": ["pharmacokinetic (PK)-pharmacodynamic (PD) parameters"]}, {"generated": ["herbal medicines", "warfarin", "PK-PD parameters"], "gold": ["PK-PD parameters"]}, {"generated": [], "gold": []}, {"generated": ["participants"], "gold": []}, {"generated": ["herb"], "gold": []}, {"generated": ["study selection", "data extraction"], "gold": []}, {"generated": ["composition", "bioanalytical data", "extraction and formulation method"], "gold": []}, {"generated": ["attrition"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["reporting percentage"], "gold": []}, {"generated": ["PD interactions of warfarin with herbal medicines"], "gold": []}, {"generated": ["herb-warfarin interaction"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["metabolism of drugs metabolized by CYP2C9"], "gold": ["CYP2C9"]}, {"generated": ["CYP enzyme activity", "liver"], "gold": ["CYP enzyme activity"]}, {"generated": [""], "gold": []}, {"generated": [], "gold": []}, {"generated": ["warfarin"], "gold": []}, {"generated": ["international normalized ratio", "activated partial thromboplastin time", "prothrombin time"], "gold": ["prothrombin time (PT)", "activated partial thromboplastin time (aPTT)", "international normalized ratio (INR)"]}, {"generated": ["disseminated intravascular coagulation (DIC)", "vitamin K malabsorption", "pathologic inhibitors of coagulation", "warfarin or super-warfarin exposure"], "gold": []}, {"generated": ["WSU Institutional Review Board"], "gold": []}, {"generated": ["blood pressure", "pulse", "oxygen saturation"], "gold": ["Vital signs (blood pressure, pulse, oxygen saturation)"]}, {"generated": ["adverse events", "beverage", "pill diary", "Siliphos", "volume used to aid swallowing", "time of administration"], "gold": ["approximate volume used to aid swallowing"]}, {"generated": ["SAS Institute", "terminal elimination rate constant"], "gold": []}, {"generated": ["constituents", "herb\u2013drug interactions", "ADME processes"], "gold": ["ADME processes"]}, {"generated": ["silibinin", "silibinin\u2013raloxifene interaction", "glucuronidation"], "gold": ["intestinal glucuronidation"]}, {"generated": ["interaction potential"], "gold": []}, {"generated": ["conjugative metabolism"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["95%", "pure powder capsule", "Curcumin"], "gold": []}, {"generated": ["percent blood glucose reduction"], "gold": []}, {"generated": ["curcumin"], "gold": []}, {"generated": ["Traditional Chinese medicine", "food", "other herbs/botanicals", "dietary supplements"], "gold": []}, {"generated": ["coadministered substances", "herbal products", "pharmacokinetic properties", "drugs", "food"], "gold": []}, {"generated": ["CBZ"], "gold": []}, {"generated": ["Cochrane Database of Systematic Reviews"], "gold": []}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": ["oral bioavailability", "pharmacokinetic parameters"], "gold": ["oral bioavailability"]}, {"generated": ["CBZ plasma level", "nicotinamide"], "gold": ["clearance"]}, {"generated": ["antiepileptic therapy"], "gold": []}, {"generated": [""], "gold": []}, {"generated": [], "gold": []}, {"generated": ["gastric absorption", "plasma level of CBZ"], "gold": []}, {"generated": ["beverage containing alcohol"], "gold": []}, {"generated": ["CBZ-related side effects", "skin rash", "dizziness", "nausea", "blurred vision"], "gold": []}, {"generated": ["individual herbs"], "gold": []}, {"generated": ["herbal medicines"], "gold": []}, {"generated": ["use of herbal medicines"], "gold": []}, {"generated": ["significant relationship"], "gold": []}, {"generated": ["Table 1"], "gold": []}, {"generated": ["age group"], "gold": []}, {"generated": ["hypoglycaemic agents", "pharmacological management", "pharmacological agents"], "gold": []}, {"generated": ["traditional use in diabetes management", "pharmacological evidence"], "gold": []}, {"generated": ["modulators", "drug interactions", "substrates", "pharmacokinetic parameters"], "gold": []}, {"generated": ["herbal medicines"], "gold": []}, {"generated": ["herb\u2013drug interactions"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["liver-specific enzymes"], "gold": ["liver-specific enzymes"]}, {"generated": ["elimination half-life"], "gold": ["an elimination half-life"]}, {"generated": ["22 compounds"], "gold": []}, {"generated": ["PNS", "BNPP"], "gold": ["BNPP"]}, {"generated": ["liver drug enzymes"], "gold": ["Liver drug enzymes"]}, {"generated": [], "gold": []}, {"generated": ["PON influence test"], "gold": ["PON"]}, {"generated": ["Total RNA"], "gold": ["Total RNA"]}, {"generated": ["HDI"], "gold": []}, {"generated": ["conceived and designed the whole experiments"], "gold": []}, {"generated": ["p-values"], "gold": []}, {"generated": ["pharmacological safety"], "gold": []}, {"generated": ["drug transporters", "cytochrome P450 enzymes"], "gold": []}, {"generated": ["intracellular calcein fluorescence", "P-glycoprotein"], "gold": []}, {"generated": ["CYP2C19 inhibition", "CYP3A4 inhibition"], "gold": []}, {"generated": ["aryl hydrocarbon receptor (AhR)", "Samento", "omeprazole"], "gold": []}, {"generated": ["drug transporters", "drug metabolizing enzymes"], "gold": []}, {"generated": ["drug transporters", "drug metabolizing enzymes"], "gold": ["bioavailability"]}, {"generated": ["pheophorbide A", "BCRP"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Banderol", "Samento"], "gold": []}, {"generated": ["RNA", "cDNA"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Banderol", "Samento"], "gold": []}, {"generated": ["MDCKII-BCRP cells", "P388 and P388/dx cells", "HEK-OATP1B1 and HEK-OATP1B3 cell lines", "AZ-AhR cells"], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["pregnane x receptor (PXR) activity"], "gold": []}, {"generated": ["protein expression of P-glycoprotein (P-gp)"], "gold": []}, {"generated": ["CYP2J2 mRNA decay"], "gold": []}, {"generated": ["RT-PCR", "\u03b22mg", "t = 0", "CYP2J2 mRNA"], "gold": []}, {"generated": ["drug interactions"], "gold": []}, {"generated": ["tablet form"], "gold": []}, {"generated": ["aqueous suspension", "Korean Pharmaceutical Codex"], "gold": []}, {"generated": ["Paeoniae Radix", "Cinnamomi cortex", "Poria Sclerotium", "Antelopis Cornu", "Bovis Calculus", "Dioscoreae Rhizoma", "Glycyrrhizae Radix et Rhizoma", "Bupleuri Radix", "Saposhnikoviae Radix", "Scutellariae Radix", "Glycine Semen Germinatum", "Ginseng Radix", "Cnidii Rhizoma", "Atractylodis Rhizoma Alba", "Liriopis Tuber", "Angelicae Gigantis Radix", "Massa Medicata Fermentata", "Platycodonis Radix", "Armeniacae Semen", "Borneolum"], "gold": []}, {"generated": ["over the counter medications", "prescription medications"], "gold": []}, {"generated": ["CYP2B6 genotyping"], "gold": []}, {"generated": ["safety monitoring"], "gold": []}, {"generated": ["positive ion mode", "5500 V", "500\u00b0C"], "gold": []}, {"generated": ["Applied Biosystems", "version 1.4", "Foster City, CA", "Analyst software"], "gold": []}, {"generated": ["Cmax", "AUC(0,\u221e)"], "gold": ["AUC(0,\u221e)", "Cmax"]}, {"generated": ["90% confidence intervals", "geometric mean ratios"], "gold": []}, {"generated": ["blood pressure", "heart rate", "body temperature"], "gold": ["blood pressure", "heart rate", "body temperature"]}, {"generated": ["bupropion", "CYP2B6 inhibitory effects", "pharmacokinetics"], "gold": []}, {"generated": ["grapefruit", "statins", "pomegranate"], "gold": []}, {"generated": ["tyrosine kinases"], "gold": []}, {"generated": ["Pgp/MDR1 protein"], "gold": []}, {"generated": ["BCRP/ABCG2 protein expression"], "gold": []}, {"generated": ["BCPR/ABCG2 protein", "DAS", "inhibition"], "gold": []}, {"generated": ["drug transporters", "drug-metabolizing enzymes (DME)"], "gold": []}, {"generated": ["APG", "DAS"], "gold": []}, {"generated": ["pharmacokinetic parameters"], "gold": []}, {"generated": ["12-h light/dark cycle", "12 h fasting", "25 \u00b0C"], "gold": []}, {"generated": ["Group II", "Group I", "DAS (25 mg/kg)"], "gold": []}, {"generated": ["Group IV", "APG 40 mg/kg administration", "2 h after", "7th day"], "gold": []}, {"generated": ["electrospray ionization"], "gold": []}, {"generated": ["APG\u2013DAS interaction"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["supervision"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["KSU-SE-21-58", "Research Ethics Committee of King Saud University College of Pharmacy Riyadh"], "gold": []}, {"generated": ["average", "SD"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["cytochrome P-450 activity"], "gold": []}, {"generated": ["CYP activity"], "gold": []}, {"generated": ["botanical supplements"], "gold": []}, {"generated": ["quadriceps muscle strength (QMS)", "lactate at rest"], "gold": ["quadriceps muscle strength (QMS)", "lactate"]}, {"generated": ["QMS", "lactate level"], "gold": ["lactate level"]}, {"generated": ["muscle strength"], "gold": ["muscle strength"]}, {"generated": ["2 min", "angular velocity", "isokinetic knee extensions"], "gold": []}, {"generated": ["femoral epicondyles", "knee joint center", "isokinetic dynamometer"], "gold": []}, {"generated": ["plasma samples"], "gold": []}, {"generated": ["SC extract supplementation", "placebo compliance"], "gold": []}, {"generated": ["height", "weight", "BMI"], "gold": ["BMI"]}, {"generated": ["resting lactate level"], "gold": ["lactate level"]}, {"generated": ["reduced oxidative metabolism", "high lactate production"], "gold": ["lactate"]}, {"generated": ["bioavailability", "efficacy"], "gold": ["bioavailability"]}, {"generated": ["pregnane\u2010X\u2010receptor (PXR) activation"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["flavonoids", "hyperforin", "hypericin"], "gold": []}, {"generated": ["time of immobility"], "gold": []}, {"generated": ["PXRRE", "xenosensor", "PXR", "xenobiotic receptor"], "gold": []}, {"generated": ["OATP2B1", "hyperforin"], "gold": []}, {"generated": ["clinically relevant interactions"], "gold": []}, {"generated": ["bioinformatics", "data mining", "pharmacoepidemiology methods"], "gold": []}, {"generated": ["clinical outcomes"], "gold": []}, {"generated": ["dosage differences"], "gold": []}, {"generated": ["database searching", "literature selection"], "gold": []}, {"generated": ["T cells count (CD4, CD4/CD8)", "intestinal damage caused by 5-FU", "delayed hypersensitivity", "Bax expression", "appetite", "WBC (CD3+, CD4+ T cells, NK cells)", "cytotoxicity", "metastasis", "caspase 3 activity", "survival time", "phagocytic activity", "platelets", "tumor inhibition effect", "antibody production", "cell cycle arrest", "caspase 3 and 8 expression and activity", "T cell apoptosis", "symptomatic relief"], "gold": ["T cell apoptosis", "caspase 3 activity", "Bax expression", "cells count", "CD4", "CD4", "CD8", "WBC", "CD3+", "CD4+ T cells", "NK cells", "platelets", "WBC", "platelets", "bone marrow cells", "phagocytic activity", "antibody production", "caspase 3"]}, {"generated": ["tumor recurrence", "metastasis"], "gold": []}, {"generated": ["reactive oxygen species production", "tumor cell angiogenesis"], "gold": []}, {"generated": ["gut dysbiosis", "Warburg-related proteins"], "gold": []}, {"generated": ["lipid peroxide levels", "cytotoxic and tumor-infiltrating lymphocytes", "superoxide dismutase (SOD)", "suppressor T cells"], "gold": ["suppressor T cells", "superoxide dismutase (SOD)", "lipid peroxide levels"]}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": ["caspase 3", "Foxp3", "Bax", "T-bet", "PD-1", "GATA-3"], "gold": []}, {"generated": ["medicinal mushrooms"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["accountability", "integrity", "work", "accuracy"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["complementary and alternative (CAM) treatment options"], "gold": []}, {"generated": ["estrogen receptor (ER) positive"], "gold": []}, {"generated": ["Viscum album extracts", "breast cancer patients", "other types of cancer"], "gold": []}, {"generated": ["total mistletoe lectin concentration"], "gold": []}, {"generated": ["HLMs", "\u03b2-estradiol", "dextrorphan-d"], "gold": []}, {"generated": ["proliferation"], "gold": []}, {"generated": ["poor", "ultra-rapid metabolizers", "extensive", "intermediate"], "gold": []}, {"generated": ["long-term outcomes in breast cancer", "CYP2D6 metabolic activity"], "gold": []}, {"generated": ["genetic polymorphisms", "CYP2D6 activity"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["CYP2D6", "quinidine"], "gold": []}, {"generated": ["institutional affiliations", "jurisdictional claims"], "gold": []}, {"generated": ["pharmacokinetic interactions"], "gold": []}, {"generated": ["ammonia solution", "2-4-dibromoacetophenone", "plasma captopril"], "gold": []}, {"generated": ["captopril dose", "p.o."], "gold": []}, {"generated": ["anaesthetized"], "gold": []}, {"generated": ["body fluid"], "gold": []}, {"generated": ["within-run accuracy", "precision"], "gold": []}, {"generated": ["rats plasma"], "gold": []}, {"generated": ["2-4-dibromoacetophenone", "sulfhydryl group"], "gold": []}, {"generated": ["Ammonia"], "gold": []}, {"generated": ["formic acid"], "gold": []}, {"generated": ["expression of the PEPT1 transporter", "GSH level"], "gold": []}, {"generated": ["Eng et al."], "gold": []}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": ["laboratory rodent chow"], "gold": []}, {"generated": ["Agilent 1290 series liquid chromatography system"], "gold": []}, {"generated": ["Student\u2019s paired t-test"], "gold": []}, {"generated": ["herb-drug interaction"], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Eugenia jambolana"], "gold": []}, {"generated": ["blood glucose level"], "gold": ["blood glucose level"]}, {"generated": ["bioactive constituents", "dipeptidyl peptidase-4 (DDP-4)"], "gold": []}, {"generated": ["safety", "efficacy"], "gold": []}, {"generated": ["Eugenia jambolana", "aqueous extract", "dried seed", "double maceration technique"], "gold": []}, {"generated": ["filtrate"], "gold": []}, {"generated": ["filtrate"], "gold": []}, {"generated": ["glucose level"], "gold": ["Glucose level"]}, {"generated": ["3a", "3b"], "gold": []}, {"generated": ["PRM", "SITA"], "gold": []}, {"generated": ["inflammatory response", "oxidative stress"], "gold": []}, {"generated": ["SEM", "mean"], "gold": []}, {"generated": ["normal group", "diabetic control group"], "gold": []}, {"generated": ["BUN levels"], "gold": ["BUN"]}, {"generated": ["Table 2"], "gold": []}, {"generated": ["normal group", "diabetic control group"], "gold": []}, {"generated": ["pharmacokinetic parameters"], "gold": []}, {"generated": ["indomethacin", "feces", "metabolites", "bile"], "gold": []}, {"generated": ["plasma sample preparation", "tissue homogenates"], "gold": []}, {"generated": ["model group", "M-AOE group"], "gold": []}, {"generated": ["4\u20135 h", "2\u20133 h", "6\u20137 h", "3\u20134 h", "5\u20136 h", "1\u20132 h", "0\u20131 h"], "gold": []}, {"generated": ["6\u201318 h", "18\u201328 h", "0\u20136 h"], "gold": []}, {"generated": ["recovery", "precision", "matrix effect", "accuracy", "stability", "selectivity", "dilution integrity", "linearity"], "gold": []}, {"generated": ["pharmacokinetics"], "gold": []}, {"generated": ["plasma concentration-time curves"], "gold": []}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": ["1.875 mg", "warfarin", "1.7\u20132.5", "INR"], "gold": ["INR", "monitoring"]}, {"generated": ["anticoagulant therapy", "thrombin times (TTs)", "moderate intake of alcohol"], "gold": ["thrombin times (TTs)"]}, {"generated": ["Danshen", "Ginkgo biloba", "Dong quai"], "gold": []}, {"generated": ["Gouqizi"], "gold": []}, {"generated": ["atrial fibrillation", "warfarin", "China", "bleeding"], "gold": []}, {"generated": ["concomitantly taking warfarin", "prosthetic heart values", "daily Gouqizi dose"], "gold": []}, {"generated": ["conflict of interests"], "gold": []}, {"generated": ["Lycium barbarum L.", "warfarin"], "gold": []}, {"generated": ["blood pressure"], "gold": ["blood pressure"]}, {"generated": ["anthocyanins", "cyanidin-3-sambubioside", "delphinidin-3-sambubioside"], "gold": []}, {"generated": ["antioxidant activity"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["LDL-C", "HDL-C", "triglycerides", "total cholesterol"], "gold": ["Cholesterol", "cholesterol", "total cholesterol", "HDL-C", "LDL-C", "triglycerides"]}, {"generated": ["total cholesterol"], "gold": ["total cholesterol"]}, {"generated": ["RCT", "study design"], "gold": []}, {"generated": [], "gold": ["calcium influx", "myocardial mass", "blood viscosity", "cyclooxygenase inhibitory activity", "adipocyte differentiation", "PI3-K/Akt", "ERK"]}, {"generated": ["kidney function", "hepatotoxicity", "liver function"], "gold": []}, {"generated": ["electrolyte levels"], "gold": ["electrolyte levels"]}, {"generated": [""], "gold": []}, {"generated": ["interaction"], "gold": []}, {"generated": ["bosutinib systemic exposure"], "gold": []}, {"generated": ["herb\u2013drug interactions", "drug metabolism", "modelling and simulation", "physiologically\u2010based pharmacokinetic (PBPK)"], "gold": []}, {"generated": ["herb\u2013drug interactions"], "gold": []}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": [""], "gold": []}, {"generated": [], "gold": ["recombinant CYP2C8 enzyme (supersomes)", "human liver microsomes (HLM)"]}, {"generated": ["NADPH", "cooling block"], "gold": ["NADPH"]}, {"generated": ["noncompetitive", "competitive", "mixed-inhibition"], "gold": []}, {"generated": ["noncompetitive inhibition", "K m values", "competitive inhibition"], "gold": ["concentrations of substrates", "K m values"]}, {"generated": ["Partition coefficients (log P)"], "gold": ["Partition coefficients (log P)"]}, {"generated": ["log P", "tissue composition", "K p (tissue\u2010to\u2010plasma partition coefficients)"], "gold": ["log P", "K p (tissue\u2010to\u2010plasma partition coefficients)"]}, {"generated": ["PBPK model prediction", "clinically-reported parameter values", "pharmacokinetic parameters"], "gold": []}, {"generated": ["midazolam", "PBPK models", "Schisandra lignans", "tacrolimus"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["MBI"], "gold": []}, {"generated": ["CYP3A inhibition"], "gold": []}, {"generated": ["Schisandra lignans"], "gold": ["CYP"]}, {"generated": ["anti\u2010cancer activity"], "gold": []}, {"generated": ["haemorrhage"], "gold": []}, {"generated": ["Danshen", "warfarin", "Gegen"], "gold": []}, {"generated": ["protein expression", "mRNA expression"], "gold": []}, {"generated": ["TM", "VKOR"], "gold": []}, {"generated": ["thin layer chromatography", "Chinese Pharmacopoeia 2005", "morphological authentication"], "gold": []}, {"generated": ["naringin", "diclofenac sodium"], "gold": []}, {"generated": ["5 min", "30 min", "12 min", "solvent A", "17%", "35%", "10 min", "13 min", "90%", "5%", "10%", "15 min"], "gold": []}, {"generated": ["mRNA expression ratio of CYP2C6"], "gold": []}, {"generated": ["mRNA expression level of CYP2C6"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["TM", "platelet aggregation", "microcirculation", "VKOR"], "gold": []}, {"generated": ["PT time", "warfarin plasma concentration"], "gold": ["PT time"]}, {"generated": ["Gegen"], "gold": []}, {"generated": ["Danshen"], "gold": []}, {"generated": ["CYP enzymes"], "gold": []}, {"generated": ["catalytic activity", "catalytic specificity"], "gold": []}, {"generated": ["warfarin dose", "genetic factors", "predictive models", "physical factors"], "gold": []}, {"generated": ["CYP2C-", "CYP3A-inducing agents", "CYP1A-"], "gold": []}, {"generated": ["warfarin hydroxylation"], "gold": []}, {"generated": ["bioavailability", "SAB"], "gold": ["bioavailability"]}, {"generated": ["discrepancies observed between the in vitro and in vivo results"], "gold": []}, {"generated": ["cyclosporine", "vitamin K epoxide reductase", "Danshen\u2013Gegen Formula", "phenobarbital", "beta-naphthoflavone", "enzyme-linked immunosorbent assay", "salvianolic acid B", "thrombomodulin", "liver cytochrome P450", "vitamin K"], "gold": []}, {"generated": ["toxicity profile"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["analyte"], "gold": []}, {"generated": ["endogenous peaks"], "gold": []}, {"generated": ["mean of 37 months", "range 4\u2013113 months"], "gold": []}, {"generated": ["conflicts of interests"], "gold": []}, {"generated": ["herbal medicines", "dietary supplements"], "gold": []}, {"generated": ["asthma", "hypertension", "minor ailments", "antimicrobials", "antimalarials", "diabetes", "peptic ulcer", "cancer"], "gold": []}, {"generated": ["isoenzymes"], "gold": []}, {"generated": ["metabolic capacity of CYP isoenzymes"], "gold": []}, {"generated": ["freeze\u2010dried"], "gold": []}, {"generated": ["Acetic acid", "HPLC\u2010grade acetonitrile"], "gold": []}, {"generated": ["concentration used in the N\u2010in\u2010one assay", "CYP isoenzymes"], "gold": []}, {"generated": ["positive ion mode", "MRM mode"], "gold": []}, {"generated": ["50% inhibitory concentration", "concentration of aqueous extract of herb"], "gold": ["Fifty percent inhibitory concentration"]}, {"generated": [], "gold": []}, {"generated": ["major human CYP isoenzymes"], "gold": []}, {"generated": ["enzyme sources", "extraction procedure", "type of the extract", "assay method", "CYP isoenzymes", "concentration"], "gold": []}, {"generated": ["aqueous extract", "Allium sativum bulbs"], "gold": []}, {"generated": ["CYP2C9", "CYP1A2"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["(2000)"], "gold": []}, {"generated": ["CYP2C19", "CYP3A4", "CYP1A2"], "gold": ["IC"]}, {"generated": ["menopause symptoms", "polyherbal formulation"], "gold": []}, {"generated": ["sleep disturbances", "weight gain", "night sweats", "sexual dysfunction", "mood disorders", "hot flashes", "cognitive declines"], "gold": []}, {"generated": ["ammonium acetate"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["gastrointestinal disease", "cardiovascular disease", "neurologic disease/disorder", "hepatic disease", "endocrine disease", "pulmonary disease", "dermatologic disease", "renal disease", "immunologic disease", "hematologic disease"], "gold": []}, {"generated": ["pregnant", "breastfeeding", "planning to conceive within 30 days of treatment cessation"], "gold": ["serum human chorionic gonadotropin"]}, {"generated": ["double-blind", "MenoAct851 formulation", "placebo"], "gold": []}, {"generated": ["sequentially numbered drug containers"], "gold": []}, {"generated": ["simvastatin", "internal standard", "simvastatin hydroxy acid", "plasma concentrations", "lovastatin"], "gold": []}, {"generated": ["SD", "mean"], "gold": []}, {"generated": ["P < 0.05"], "gold": []}, {"generated": ["40 mg simvastatin"], "gold": []}, {"generated": ["herbal medicines", "bioavailability", "herbal formulations"], "gold": ["bioavailability"]}, {"generated": ["stent", "hypertension", "bleeding", "fatigue", "diabetes"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["interactions between medication and lifestyle"], "gold": []}, {"generated": ["drug \u2013 lifestyle", "drug interactions"], "gold": []}, {"generated": ["echinacea", "policosanol"], "gold": []}, {"generated": ["CYP2C9*1", "CYP2C9*3", "CYP2C9*2"], "gold": []}, {"generated": ["adverse events"], "gold": []}, {"generated": ["Collagen", "Geometric mean ratio to control (90% CI)", "Mean (95% CI)", "Platelet aggregation (Ohms)", "Open in a separate window", "Adenosine diphosphate", "Arachidonic acid"], "gold": ["Platelet aggregation"]}, {"generated": ["trough plasma concentrations", "Cmax"], "gold": ["Cmax"]}, {"generated": ["warfarin pharmacodynamics", "pharmacokinetics"], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["herb-drug use", "awareness of herb-drug use"], "gold": []}, {"generated": ["Allium sativum", "Panax ginseng", "Ginkgo biloba", "Hypericum perforatum"], "gold": []}, {"generated": ["CYP1A2 activity"], "gold": []}, {"generated": ["CYP assays"], "gold": []}, {"generated": ["\u03b2-Sitosterol", "5\u2032-methoxydehydropodophyllotoxin", "deoxydehydropodophyllotoxin", "4\u2032-demethyldesoxypodophyllotoxin", "dehydropodophyllotoxin", "cadina-4,10(15)-dien-3-one", "dehydro-b-peltatin methyl ether"], "gold": []}, {"generated": ["type 1 Whatman filter paper", "suction-filtered"], "gold": []}, {"generated": ["chromatographic methods"], "gold": []}, {"generated": ["Waters LCT Time of Flight Mass Spectrometer", "Waters Alliance 2690 HPLC", "High resolution LC-MS"], "gold": []}, {"generated": ["CYPs 1A1, 1A2, 1B1, 3A4, 2D6", "cytochrome P450 enzymes"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["concentrations of the extracts", "2,2-diphenyl-1-picrylhydrazyl (DPPH)"], "gold": []}, {"generated": ["phytochemicals", "dried", "aerial", "aqueous extract", "H. verticillata"], "gold": []}, {"generated": ["area under the plasma concentration-time curve", "area under the first moment of plasma drug concentration-time curve"], "gold": ["area under the plasma concentration-time curve", "area under the first moment of plasma drug concentration-time curve"]}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["symptoms"], "gold": []}, {"generated": ["treatment", "rashes caused by Lomatium"], "gold": []}, {"generated": ["rash", "antihistamines"], "gold": []}, {"generated": ["selected single herbs", "Wen Bing formulas", "OS"], "gold": []}, {"generated": ["batch number", "quality of control standard number", "Radix Scutellariae extract"], "gold": []}, {"generated": ["Albuterol"], "gold": []}, {"generated": ["Hygromycin B", "glycyl-sarcosine (Gly-Sar)", "thiazolyl blue tetrazolium bromide (MTT)"], "gold": []}, {"generated": ["PBS", "dichlorvos"], "gold": []}, {"generated": ["antiviral activity"], "gold": []}, {"generated": ["rat plasma", "OS"], "gold": []}, {"generated": ["OSA"], "gold": []}, {"generated": ["ten marker components"], "gold": []}, {"generated": ["metabolism", "HDI", "absorption"], "gold": []}, {"generated": ["systemic exposure of OS", "OSA"], "gold": []}, {"generated": ["OSA/OS ratio"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["enzymes", "cells", "influenza viruses", "microsomes"], "gold": []}, {"generated": ["herbal components", "hydrolysis of OS", "herbal extracts"], "gold": []}, {"generated": ["hydrolysis enzymes", "hydrolase activities"], "gold": []}, {"generated": ["absolute z-score", "HDI relevancy with OS"], "gold": []}, {"generated": [], "gold": ["BIO", "AUC"]}, {"generated": ["Radix Isatidis"], "gold": []}, {"generated": ["Fructus Arctii"], "gold": []}, {"generated": ["drug interactions"], "gold": []}, {"generated": ["clinical evidence", "natural products", "TAM"], "gold": []}, {"generated": ["complementary and alternative medicine (CAM) treatment"], "gold": []}, {"generated": ["Anemarrhena", "Phellodendron bark"], "gold": []}, {"generated": ["Lilyturf", "Licorice", "Ginger"], "gold": []}, {"generated": ["cell cycle arrest", "autophagy", "apoptosis"], "gold": []}, {"generated": ["cell apoptosis", "anti-proliferative effect"], "gold": []}, {"generated": ["synergistic inhibitory effect"], "gold": ["MCF-7 and T-47D cell growth"]}, {"generated": ["Mistletoe (Viscum album L.) derived medicinal preparations"], "gold": []}, {"generated": ["apoptosis", "cell viability", "TAM resistance", "cell growth"], "gold": ["cell viability", "cell growth"]}, {"generated": ["12 traditional herbs", "Jaeumkanghwa soup"], "gold": []}, {"generated": ["Jiawei Xiaoyao San"], "gold": []}, {"generated": ["protective effect"], "gold": []}, {"generated": ["antioxidant enzymes", "TBARS", "sGOT", "liver transaminases", "glutathione", "sGPT"], "gold": ["antioxidant enzymes", "the activity of sGPT and sGOT", "glutathione concomitant", "TBARS", "liver transaminases"]}, {"generated": ["protein expression levels", "transcription activity"], "gold": ["protein expression levels"]}, {"generated": ["BCRP", "MDR1", "OAT1/3"], "gold": []}, {"generated": ["Communicable diseases", "lead causes of death and disability", "WHO\u2019s Global Health Estimates 2000\u20132019", "GBD Diseases and Injuries, 2020"], "gold": []}, {"generated": ["prostatitis", "urinary tract infections", "pyelonephritis"], "gold": []}, {"generated": ["PCE tracer components"], "gold": []}, {"generated": ["CIP", "urine"], "gold": []}, {"generated": ["ATP-binding cassette transporters"], "gold": []}, {"generated": ["gradient elution program"], "gold": []}, {"generated": ["PCA", "GA", "CIP"], "gold": []}, {"generated": ["precursor-product ion transitions"], "gold": []}, {"generated": ["PCA", "GA", "PK changes"], "gold": []}, {"generated": ["K tissue distribution coefficients", "tissue distribution curves", "tissue distribution profiles", "tissue to plasma distribution coefficients"], "gold": []}, {"generated": ["tissue distribution profiles", "tissue to plasma distribution coefficients"], "gold": []}, {"generated": ["renal epithelia", "intestinal epithelia"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["potential conflict of interest"], "gold": []}, {"generated": [""], "gold": []}, {"generated": [], "gold": []}, {"generated": ["air temperature", "barometric pressure", "relative humidity"], "gold": []}, {"generated": ["extremely"], "gold": []}, {"generated": ["total AUC"], "gold": ["AUC", "CHO"]}, {"generated": ["exercise time", "Total Energy Expenditure (TEE)", "treatment (YM vs. PLC)"], "gold": ["Total Energy Expenditure (TEE)"]}, {"generated": ["24% increase"], "gold": []}, {"generated": ["RER", "metabolic rate", "blood lipid metabolites"], "gold": []}, {"generated": ["mono-caffeolquinic acids", "quinic acid", "anti-lipolytic", "hypocholesterolemic properties", "caffeic acid", "minerals", "vitamins", "di-caffeolquinic acids", "adrengenic effects", "triterpenic saponins"], "gold": []}, {"generated": ["bioavailability", "active ingredients"], "gold": ["bioavailability"]}, {"generated": ["psychomotor effects", "mood state", "satiety"], "gold": []}, {"generated": ["fat-loss outcomes", "BF%", "physically active", "YM"], "gold": []}, {"generated": ["R.A."], "gold": []}, {"generated": ["Prof. Yeong Bae Seo"], "gold": []}, {"generated": ["OCT1", "OATP1B3", "OCT2", "OAT3", "OATP1B1", "OAT1"], "gold": ["OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters"]}, {"generated": ["water", "food"], "gold": []}, {"generated": ["polyethylene tubing", "jugular vein"], "gold": ["anesthesia"]}, {"generated": ["data processing", "LC-MS/MS system control", "Mass Hunter software"], "gold": []}, {"generated": ["concomitant herbal use"], "gold": []}, {"generated": ["felodipine", "cytochrome P450", "P-glycoprotein"], "gold": []}, {"generated": ["ginseng", "piperine", "St. John\u2019s wort", "valerian", "kratom", "rhodiola", "moringa", "terminalia/commiphora ayurvedic mixture", "ginkgo", "celery", "kava", "hydroxycut", "echinacea"], "gold": []}, {"generated": ["bioactive components", "CYP450 family", "DMEs"], "gold": []}, {"generated": ["Anecdotal evidence", "clinical decisions", "consequences of HDIs"], "gold": []}, {"generated": ["fatigue and general well-being", "cardiovascular disorders", "symptoms of cognition decline and memory loss", "anxiety and mood disorders"], "gold": []}, {"generated": ["subtherapeutic serum levels", "seizure", "toxicological autopsy"], "gold": []}, {"generated": ["midazolam", "AUC", "pharmacokinetic parameters", "CYP3A4"], "gold": ["AUC"]}, {"generated": ["manic psychosis"], "gold": []}, {"generated": ["kavalactones"], "gold": []}, {"generated": ["CNS benefits"], "gold": []}, {"generated": ["clinically relevant interaction"], "gold": []}, {"generated": ["alertness", "circulation", "diarrhea", "diabetes", "libido", "concentration"], "gold": []}, {"generated": ["serotonergic effects", "CYP/P-gp induction"], "gold": []}, {"generated": ["CYP3A4"], "gold": []}, {"generated": ["oral administration"], "gold": []}, {"generated": ["dietary supplements"], "gold": []}, {"generated": ["CYP3A4", "P-gp"], "gold": []}, {"generated": ["neuropsychiatric drugs"], "gold": []}, {"generated": ["bioactive compounds"], "gold": []}, {"generated": ["calcineurin inhibitors"], "gold": []}, {"generated": ["narrow therapeutic window"], "gold": []}, {"generated": ["sirolimus", "tacrolimus", "tremors"], "gold": []}, {"generated": ["serum creatinine level"], "gold": ["serum creatinine level"]}, {"generated": ["herb\u2013drug interactions"], "gold": []}, {"generated": ["author contributions"], "gold": []}, {"generated": ["immunosuppressive drug"], "gold": []}, {"generated": ["immunosuppressive drugs"], "gold": []}, {"generated": ["Parsley"], "gold": []}, {"generated": ["transporter proteins", "metabolizing enzymes"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["serum creatinine level"], "gold": ["serum creatinine level"]}, {"generated": ["level of sirolimus"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["S. D.", "n", "mean"], "gold": []}, {"generated": ["AUC data", "herb-drug interaction"], "gold": ["AUC"]}, {"generated": ["et Zucc."], "gold": []}, {"generated": ["pretreatment period"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Maxim extract"], "gold": []}, {"generated": ["Bilia and C\u00e9u Costas review"], "gold": []}, {"generated": ["knowledge of risks", "knowledge of benefits"], "gold": []}, {"generated": ["analgetic drugs"], "gold": []}, {"generated": ["species"], "gold": []}, {"generated": ["prevalence"], "gold": []}, {"generated": ["geographical area of this review", "species used"], "gold": []}, {"generated": ["plants"], "gold": []}, {"generated": ["Aloe vera"], "gold": []}, {"generated": ["hepatotoxic herbs"], "gold": []}, {"generated": ["opioids", "short-term use", "surgical intervention", "pain relief"], "gold": []}, {"generated": ["liver injury"], "gold": []}, {"generated": ["product quality"], "gold": []}, {"generated": ["cannabis preparations"], "gold": []}, {"generated": ["possible beneficial effects"], "gold": []}, {"generated": ["Allium sativum", "pulverized dried bulbs", "0.45% allicin"], "gold": []}, {"generated": ["ginkgolic acid content"], "gold": []}, {"generated": ["anticoagulant", "platelet inhibiting co-medication", "bleeding risk"], "gold": []}, {"generated": ["thrombin inhibition"], "gold": []}, {"generated": [""], "gold": []}, {"generated": [], "gold": []}, {"generated": ["HILI", "tea consumption"], "gold": []}, {"generated": ["HILI"], "gold": []}, {"generated": ["water", "green tea"], "gold": []}, {"generated": ["CYP susceptibility"], "gold": ["CYP"]}, {"generated": ["CY3A4", "2C9"], "gold": []}, {"generated": ["platelet aggregation"], "gold": ["platelet aggregation"]}, {"generated": ["ASA", "inter-individual variability", "AUC +28%"], "gold": ["AUC"]}, {"generated": ["individual susceptibility"], "gold": ["individual susceptibility"]}, {"generated": ["natural", "adverse effects"], "gold": []}, {"generated": ["Valerian", "Garcia-Alvarez", "HMP"], "gold": []}, {"generated": ["mentions to the wrong species", "translation errors"], "gold": []}, {"generated": ["institutional affiliations", "jurisdictional claims"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["additive/synergistic interactions", "clinical safety", "clinical efficacy", "antagonistic interactions"], "gold": []}, {"generated": ["pharmacodynamic HDI"], "gold": []}, {"generated": ["allyl", "sulfur compounds", "allyl thiosulfinates"], "gold": []}, {"generated": ["diabetic treatment"], "gold": []}, {"generated": ["blood sugar levels"], "gold": ["blood sugar"]}, {"generated": ["antidiabetics", "Lycium"], "gold": []}, {"generated": ["conventional antidiabetics", "Lycium"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["system-to-system methodology", "pharmacological data"], "gold": []}, {"generated": ["synergism"], "gold": []}, {"generated": ["institutional affiliations", "jurisdictional claims"], "gold": []}, {"generated": ["asthma", "convulsions", "cough", "bronchitis", "flatulence", "hysteria"], "gold": []}, {"generated": ["DEX", "dextrorphan (DOR)"], "gold": []}, {"generated": ["DEX", "CYP2D6", "CYP3A"], "gold": ["CYP3A", "CYP2D6"]}, {"generated": ["USP reference standard"], "gold": []}, {"generated": ["General-purpose reagents", "HPLC grade solvents"], "gold": []}, {"generated": ["Zorbax SB-CN column"], "gold": []}, {"generated": ["Scheffe\u2019s multiple comparison test", "P value", "one-way analysis of variance (ANOVA)", "Asafetida", "DEX metabolites"], "gold": []}, {"generated": ["DEX", "formation of DOR"], "gold": []}, {"generated": ["25 \u03bcg/ml concentration"], "gold": []}, {"generated": ["healthy human volunteers"], "gold": []}, {"generated": ["clinical study"], "gold": []}, {"generated": ["Asafetida", "CYP3A4 metabolic activity"], "gold": []}, {"generated": ["abemaciclib-related diarrhea"], "gold": []}, {"generated": ["fatigue", "loose stools"], "gold": []}]}